Cargando…
Aminosteroid RM-581 Decreases Cell Proliferation of All Breast Cancer Molecular Subtypes, Alone and in Combination with Breast Cancer Treatments
Breast cancer (BC) is a heterogenous disease classified into four molecular subtypes (Luminal A, Luminal B, HER2 and triple-negative (TNBC)) depending on the expression of the estrogen receptor (ER), the progesterone receptor (PR) and the human epidermal receptor 2 (HER2). The development of effecti...
Autores principales: | Burguin, Anna, Roy, Jenny, Ouellette, Geneviève, Maltais, René, Bherer, Juliette, Diorio, Caroline, Poirier, Donald, Durocher, Francine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342875/ https://www.ncbi.nlm.nih.gov/pubmed/37445276 http://dx.doi.org/10.3390/jcm12134241 |
Ejemplares similares
-
Induction of Endoplasmic Reticulum Stress-Mediated Apoptosis by Aminosteroid RM-581 Efficiently Blocks the Growth of PC-3 Cancer Cells and Tumors Resistant or Not to Docetaxel
por: Maltais, René, et al.
Publicado: (2021) -
The Aminosteroid Derivative RM-133 Shows In Vitro and In Vivo Antitumor Activity in Human Ovarian and Pancreatic Cancers
por: Kenmogne, Lucie Carolle, et al.
Publicado: (2015) -
Breast Cancer Treatments: Updates and New Challenges
por: Burguin, Anna, et al.
Publicado: (2021) -
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
por: Burguin, Anna, et al.
Publicado: (2020) -
Role of Secreted Frizzled-Related Protein 1 in Early Breast Carcinogenesis and Breast Cancer Aggressiveness
por: Clemenceau, Alisson, et al.
Publicado: (2023)